Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
June 24, 2023 2:01 PM 2 min read

AI Technology Brings Innovation To Treating Stroke Patients

by Chris Bibey Benzinga Staff Writer
Follow

Artificial intelligence (AI) technology is changing the way stroke patients receive treatment. Tampa General Rehabilitation Hospital recently introduced an AI-powered device to bring speed and efficiency to the recovery process.

See Next: This Startup Invented Programmable, Drinkable Plastic That Dissolves In Water In 60 Hours

BIONIK's InMotion Robotic Arm: The Future Of Stroke Treatment

Tampa General Rehabilitation Hospital is one of the first medical facilities in Florida to implement BIONIK's InMotion robotic arm to treat stroke patients. Through the use of activities and games, therapy for stroke patients is more interactive and fun than ever before. And with that, there's a greater chance of the patient reaching their full recovery potential while avoiding the tedious nature of more traditional therapy. 

"It's more motivating for the patient. They can see real-time progress, they're more engaged in their therapies," said occupational therapist Samantha Rubio in an interview with ABC Action News Tampa Bay.

"The artificial intelligence in the device is actually very subtle, you wouldn't notice it to the naked eye. When the patient comes in, we do an evaluation where the robot learns what their current range of motion is, their current strength and what areas we still need to work on."

In other words, if the patient isn't told that BIONIK's InMotion robotic arm is powered by AI technology they'd never know. There's nothing that glaringly sticks out to the patient about the device. All they know is that the technology has the potential to improve their experience as they recover. 

Regardless of the severity, a stroke is a major medical event that can impact a person's ability to live their life. Through the use of BIONIK's InMotion robotic arm at facilities such as Tampa General Rehabilitation Hospital, patients have more hope during recovery, which gives them a better outlook on the future. 

There's a stigma that therapy has to be a long, arduous and even torturous task that generates only incremental results. AI technology is changing this as it motivates patients and gives them the hope they need to continue down the recovery path.

See more on startup investing from Benzinga.

  •  AI Startups Turn to Retail Investors To Fund the Growth of the $1.59 Trillion Artificial Intelligence Market
  • Be An Owner, Not Just A Consumer: Retail Investors Are Taking Stakes In Their Favorite Startups To Own The Upside
Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
NewsStartupsTechAIartificial intelligencestartup crowdfunding
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter
Comments
Loading...